LY2119620 | CAS#886047-22-9 | modulator

MedKoo Cat#: 584796 | Name: LY2119620

Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

LY2119620 is a positive allosteric modulator of the M2 and M4 muscarinic acetylcholine receptors (mAChRs).

Chemical Structure

LY2119620

CAS#886047-22-9

Theoretical Analysis

MedKoo Cat#: 584796

Name: LY2119620

CAS#: 886047-22-9

Chemical Formula: C19H24ClN5O3S

Exact Mass: 437.1288

Molecular Weight: 437.94

Elemental Analysis: C, 52.11; H, 5.52; Cl, 8.09; N, 15.99; O, 10.96; S, 7.32

Price and Availability

Size	Price	Availability
25mg	USD 550.00	2 weeks
50mg	USD 950.00	2 weeks
100mg	USD 1,650.00	2 Weeks

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

No Data

Synonym

LY2119620; LY 2119620; LY-2119620

IUPAC/Chemical Name

3-amino-5-chloro-N-cyclopropyl-4-methyl-6-[2-(4-methyl-1-piperazinyl)-2-oxoethoxy]-thieno[2,3-b]pyridine-2-carboxamide

InChi Key

TYTGOXSAAQWLPJ-UHFFFAOYSA-N

InChi Code

InChI=1S/C19H24ClN5O3S/c1-10-13-15(21)16(17(27)22-11-3-4-11)29-19(13)23-18(14(10)20)28-9-12(26)25-7-5-24(2)6-8-25/h11H,3-9,21H2,1-2H3,(H,22,27)

SMILES Code

O=C(C1=C(N)C2=C(C)C(Cl)=C(OCC(N3CCN(C)CC3)=O)N=C2S1)NC4CC4

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Product Data

Product Data

Instruction

View handling instruction

Biological target:

LY2119620 is a high-affinity muscarinic M2/M4 receptor agonist.

In vitro activity:

Dissociation kinetic studies using [(3)H]NMS further support that LY2119620 binds allosterically to the M2 and M4 mAChRs and was positively cooperative with muscarinic orthosteric agonists. Cooperativity binding of [(3)H]LY2119620 with mAChR orthosteric agonists detects significant changes in Bmax values with little change in Kd, suggesting a G protein-dependent process. Reference: Mol Pharmacol. 2014 Jul;86(1):116-23. https://pubmed.ncbi.nlm.nih.gov/24807966/

In vivo activity:

TBD

	Solvent	mg/mL	mM
Solubility
	DMF	50.0	114.17
	DMSO	62.1	141.74
	DMSO:PBS (pH 7.2) (1:2)	0.3	0.75
	Ethanol	1.0	2.28

Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 437.94 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:

1. Schober DA, Croy CH, Xiao H, Christopoulos A, Felder CC. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites. Mol Pharmacol. 2014 Jul;86(1):116-23. doi: 10.1124/mol.114.091785. Epub 2014 May 7. PMID: 24807966. 2. Kruse AC, Ring AM, Manglik A, Hu J, Hu K, Eitel K, Hübner H, Pardon E, Valant C, Sexton PM, Christopoulos A, Felder CC, Gmeiner P, Steyaert J, Weis WI, Garcia KC, Wess J, Kobilka BK. Activation and allosteric modulation of a muscarinic acetylcholine receptor. Nature. 2013 Dec 5;504(7478):101-6. doi: 10.1038/nature12735. Epub 2013 Nov 20. PMID: 24256733; PMCID: PMC4020789.

In vitro protocol:

In vivo protocol:

TBD

Croy, C.H., Schober, D.A., Xiao, H., et al. Characterization of the novel positive allosteric modulator, LY2119620, at the muscarinic M2 and M4 receptors Mol. Pharmacol. 86(1), 106-115 (2014).